Aflac Sets Up $215 Million Tax Allowance, But Only $51 Million Hit Net Earnings
The insurer booked $164 million of the charge through comprehensive income, as $1.1 billion of net investment losses followed a portfolio shake-up.
Aflac, which sells supplemental health and life insurance in Japan and the United States, said in its 10-Q filed Thursday that it booked a $215 million valuation allowance on deferred tax assets in the third quarter. Just $51 million reached net earnings. The other $164 million went through other comprehensive income.
Where the $215 million landed
The allowance targets deferred tax assets tied to capital loss carryforwards. Management expects part of them to expire unused.
The $51 million equals $0.10 per diluted share and sat inside net earnings of $303 million, versus $1.6 billion a year earlier.
Aflac's combined U.S. and Japanese effective tax rate was 39.6% for the third quarter, against 17.8% a year earlier, and the filing ties the gap mainly to the allowance. For the first nine months the rate was 21.1%, versus 23.4%.
A $1.1 billion portfolio reset
Net investment losses were $1.1 billion in the quarter, against gains of $275 million a year earlier, largely tied to what the company calls a strategic repositioning of its investment portfolio. They included $842 million of net losses from sales and redemptions, $146 million from certain derivative and foreign currency activity and $102 million of added credit loss allowances.
Total revenues fell to $3.3 billion from $4.7 billion. Adjusted earnings, which exclude investment gains and losses, were $1.2 billion, or $2.43 per diluted share, against $1.3 billion, or $2.49, a year earlier.
The business underneath
Aflac Japan sells cancer, medical and life insurance, while Aflac U.S. sells products such as accident, disability and critical illness coverage. Aflac U.S. pretax adjusted earnings rose 31.5% to $493 million in the quarter. Aflac Japan's fell 21.0% to $961 million.
Buybacks totaled $2.8 billion, or 24.3 million shares, leaving 90.0 million authorized. The company's market value was $62.8 billion as of Thursday.
The next quarterly filing will show whether the allowance grows or is released.
Sources
- 10-Q Filing — Aflac (AFL) — SEC EDGAR
- 10-Q Filing — Aflac (AFL), Q2 FY2026 filed 2026-08-07 (comparison basis) — SEC EDGAR
- Earnings release (8-K Item 2.02, aflex991-q32026new.htm) — Aflac, filed 2026-11-04 — SEC EDGAR
- Aflac expects Japan pretax margin of 35% to 38% as it targets 30% FSA reserves reinsurance cession (NYSE:AFL) | Seeking Alpha — seekingalpha.com
- AFLAC Incorporated (AFL) Stock Forecasts — Yahoo Finance
- Aflac (AFL) Surpasses Q3 Earnings and Revenue Estimates — Yahoo Finance
- Aflac: Q3 Earnings Snapshot – WTOP News — wtop.com
- Aflac: Q3 Earnings Snapshot — Associated Press